News

MIMS wrong on herbal data, says critic

Medicines bible, MIMS, is providing potentially erroneous product information about complementary medicines, a leading public health expert claims.

1 year ago0

Pfizer pull Thelin over liver fears

Research linking pulmonary arterial hypertension drug Thelin with irreversible liver damage has prompted manufacturer, Pfizer, to withdraw it from the market.

1 year ago0

TGA approves first prescription Omega 3 drug
A new secondary treatment containing Omega 3 has been approved for patients at risk of myocardial infarction, by the Therapeutic...
1 year ago0
Alendronate PBS listing extended
Health professionals treating patients with corticosteroid-induced osteoporosis now have reimbursed access to agents containing alendronate, including Fosamax.
1 year ago0
New PBS option for juvenile idiopathic arthritis
A second treatment option has now been approved by the Pharmaceutical Benefits Scheme for children suffering with juvenile idiopathic arthritis.
1 year ago0
Confusion over Reductil recall
Pharmacists are complaining of being left out of the loop on the withdrawal of Reductil (sibutramine) after finding out about...
1 year ago0

Features

Are you being (well) served?

Opinion

US: the health battleground?

Kos Sclavos

The US is looking to implement a new universal health care system and community pharmacy is hoping to benefit.

2 years ago 0

How many more must die?

Kos Sclavos

The existing situation where consumers are able to 'doctor shop' and purchase potentially lethal amounts of prescription medicines has an easy-to-implement solution.

2 years ago 0

Send New Password

manufacturer

News

Features

Are you being (well) served?

Opinion

US: the health battleground?

How many more must die?

Pharmacy News on Twitter